Accessibility: Skip TopNav
Results of Open Label Study of NE3107 in Alzheimer’s Disease
82% of MCI and mild AD patients had improvements in their modified ADAS-Cog12 score
Format
PNG
Source
BioVie, Inc.
Downloads
Original
Large
Medium
Small